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Progression through the mammalian cell cycle is regulated by the sequential activation and inactivation of the
cyclin-dependent kinases. In adult cells, cyclin A2-dependent kinases are required for entry into S and M phases, completion
of S phase, and centrosome duplication. However, mouse embryos lacking the cyclin A2 gene nonetheless complete
preimplantation development, but die soon after implantation. In this report, we investigated whether a contribution of
maternal cyclin A2 mRNA and protein to early embryonic cell cycles might explain these conflicting observations. Our data
show that a maternal stock of cyclin A2 mRNA is present in the oocyte and persists after fertilization until the second
mitotic cell cycle, when it is degraded to undetectable levels coincident with transcriptional activation of the zygotic
genome. A portion of maternally derived cyclin A2 protein is stable during the first mitosis and persists in the cytoplasm,
but is completely degraded at the second mitosis. The ability of cyclin A2-null mutants to develop normally from the
four-cell to the postimplantation stage in the absence of detectable cyclin A2 gene product indicates therefore that cyclin
A2 is dispensable for cellular progression during the preimplantation nongrowth period of mouse embryo
development. © 2000 Academic Press
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The developmental process in mammals and other ani-
mal species begins during oogenesis with the accumulation
of both maternal RNA and protein as the oocyte grows and
matures. In murine oocytes, mRNA accumulates linearly
with respect to oocyte volume and thereafter remains
constant (Paynton, 1988; Roller, 1989). The destruction of
some maternal mRNA starts during oocyte maturation
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rrested in the prophase of meiosis I, to an arrest in
etaphase of meiosis II. A decrease of more than 50% in
ome mRNAs occurs (Bachvarova, 1985; Paynton, 1988),
hereas the amount of other mRNAs remains unchanged
Moore, 1996). These more stable maternal mRNAs are
resumably required for cell cycle progression and early
evelopment.
In many species, transcription is effectively silent during
he period encompassing meiotic maturation and early
evelopment immediately following fertilization (Bolton,
984; Wasserman, 1988). Thus, the earliest stages of em-
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140 Winston et al.bryogenesis are regulated by maternally inherited compo-
nents stored within the oocyte. As development proceeds
and maternally inherited components decay, the process of
early embryogenesis becomes increasingly dependent on
the expression of genetic information derived from the
zygotic genome. In the mouse, embryo development can
occur solely on maternal mRNA transcripts and proteins
until the two-cell stage during the G2 phase of which the
zygotic genome expression occurs on a large scale (Flach,
1982). At the same time a loss of about 70% of maternal
polyadenylated mRNA (Clegg and Piko, 1983) and 40% of
the total maternal RNA occurs. However, 30% of the total
maternal RNA persists until the early blastocyst (Bach-
varova and De Leon, 1980).
The cell “cleavage” divisions give rise to the blastocyst in
the absence of growth. Cleavage divisions can be very rapid
in invertebrates and amphibia and have provided experi-
mental systems used to identify regulators of the cell cycle.
The first to be identified were A- and B-type cyclins, which
accumulate during interphase and are degraded at mitosis
(Evans, 1983; Swenson, 1986). Two A-type cyclins have
been characterized in vertebrates. In the mouse, cyclin A1
is expressed during meiosis in both male and female germ
cells (Sweeney, 1996), but is essential only in male cells
(Liu, 1998). In contrast, cyclin A2 is needed at two critical
points in the mitotic cell cycle of somatic adult cells, at the
G1- to S-phase transition and at the entry into mitosis
(Girard, 1991; Pagano, 1992; Zindy, 1992). In mammalian
somatic cells, cyclin A2 is degraded at each mitotic division
and must be synthesized de novo during the following
cycle. Cyclin A2 also plays a role during G2 to prevent
rereplication of the genome. Mutations in Drosophila cy-
clin A lead to an arrest in G2 and endoreduplication of DNA
in the absence of mitosis (Lehner and O’Farrell, 1990; Sauer,
1995).
Previously we have shown that murine embryos lacking
the cyclin A2 gene develop to the late blastocyst stage,
implant in the uterine wall, but fail to develop past 5.5 days
postcoitum (pc) (Murphy, 1997). In this study, we have
examined the stability of maternally inherited cyclin A2
mRNA to determine whether it might be essential to
support these cell divisions in the murine embryo. We also
assessed the levels and cellular distribution of the cyclin A2
protein. The results show that maternal stocks of both
cyclin A2 mRNA and protein are degraded to undetectable
levels during the two- to four-cell transition. Therefore,
cyclin A2 is not required for the subsequent cell division
cycles until 5.5 days pc. We also show that cyclin A2 is not
needed for DNA replication in the early mouse embryo.
MATERIALS AND METHODS
Collection and Culture of Oocytes and Embryos
Wild-type F1 mice (C57B/6 3 CBA) were obtained from INRA
Jouy-en-Josas, France). Mice heterozygous (1/2) or homozygous
ild type (1/1) for the cyclin A2 gene (Balb/c 3 129 Sv/J mixed c
Copyright © 2000 by Academic Press. All rightgenetic background) were genotyped by PCR using primers specific
for the lacZ reporter gene, which replaces the cyclin A2 transcribed
region in the mutant allele (Murphy, 1997). Mice harboring the
cyclin A2 wild-type Balb/c allele were selected by restriction digest
of tail DNA samples followed by Southern blotting and used for all
experiments.
Immature oocytes displaying a germinal vesicle (GV) were ob-
tained from ovaries removed from 5- to 6-week-old female mice
and transferred to prewarmed (37°C) M2 medium supplemented
with 4 mg/mL bovine serum albumin (M21BSA; Whittingham,
1971), with or without 50 mg/mL dibutyryl cyclic AMP (dbcAMP;
Sigma), which prevents germinal vesicle breakdown (GVBD).
Ovulated oocytes arrested in metaphase II (MII) were recovered
from the fallopian tubes of female mice superovulated by intraperi-
toneal injections of 10 iu of pregnant mare’s serum gonadotrophin
(Intervet) and human chorionic gonadotrophin (Intervet) 48 h apart.
To obtain embryos, females were paired overnight with males.
Embryos at the one-cell to morula stages were either flushed from
the oviducts at the stage to be examined or derived by culture in
vitro of earlier stages in T6 medium supplemented with BSA under
oil (BDH Chemicals, UK) in 5% CO2 at 37°C.
Embryo bisection was carried out according to Tarkowski and
Rossant (1976) modified by Kubiak (1993). After bisection, 300
nucleate or anucleate approximately equal-sized halves of one-cell
embryos or 600 equal-sized halves of two-cell embryo blastomeres
were washed in M2 medium containing 4 mg/mL polyvinylpyrro-
lidone (M21PVP) and collected for immunoblotting.
Blastocysts 3.5 days pc were flushed from the uterine horns and
either collected immediately for analysis or cultured in vitro on
gelatin-coated glass coverslips in supplemented DMEM (Hogan,
1994; Hendrey, 1995).
Staining for b-Galactosidase Activity
Expression of the lacZ reporter gene was assessed in oocytes and
embryos fixed in 0.1 M phosphate buffer (pH 7.3) containing 0.2%
glutaraldehyde, 5 mM EGTA, and 2 mM MgCl2 for 10 min at room
temperature and then permeabilized by three rinses in phosphate
buffer with 2 mM MgCl2, 0.1% sodium deoxycholate, 0.2% NP-40.
After extensive washing in phosphate buffer, b-galactosidase activ-
ity was detected using the chromogenic substrate X-gal (Vernet,
1993).
a-Amanitin, Cycloheximide, and Nocodazole
Treatments
Fertilized eggs and embryos were cultured in the presence or
absence of 11 mg/mL a-amanitin to inhibit specifically and irre-
versibly RNA polymerase II in mouse embryos (Levey and Brinster,
1978). At the end of the incubation period and careful rinsing in
M21PVP, individual oocytes and embryos were collected in a 2-mL
volume of diethyl pyrocarbonate-treated double distilled sterile
water and frozen immediately at 280°C for RT-PCR analysis.
One-cell or two-cell stage embryos, recovered in G2 phase of the
cell cycle, were cultured in the presence or absence of 400 mM
ycloheximide, known to inhibit more than 95% of protein syn-
hesis (Howlett, 1986). At the end of the incubation period, groups
f divided and nondivided embryos were collected separately,
insed in M21PVP, and lysed in sample buffer (Lae¨mmli, 1970) for
mmunoblot analysis.
One-cell or two-cell stage embryos, recovered in G2 phase of the
ell cycle, were cultured in the presence of 10 mM nocodazole for a
s of reproduction in any form reserved.
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141Stability of Maternally Inherited Cyclin A2maximum of 3 h until they had arrested in metaphase. Embryos
were then either collected or cultured for a further period without
the drug until the onset of cytokinesis.
mRNA Detection Using RT-PCR
Single oocytes and embryos were analyzed for the presence of
cyclin A2, cdc25, or b-tubulin mRNAs using RT-PCR. Reverse
ranscription was carried out in a final volume of 20 mL of reaction
ix containing 10 mM Tris–HCl (pH 8.0), 50 mM KCl, 5 mM
gCl2, 62.5 mM dNTP (Gibco BRL), 100 ng random primers (Pdn6;
Pharmacia Biotech), 200 U reverse transcriptase (MMLV; Gibco
BRL), and 20 U RNase inhibitor. Samples were kept frozen until
addition of the reaction mix and incubation at 37°C for 1 h. The
total contents of each RT reaction tube were then added to PCR
tubes prepared with 30 mL of standard reaction mix under paraffin
oil (Sigma) and mixed by pipetting. Using 38 cycles of amplification
and an annealing temperature of 58°C, cyclin A2 primers generate
a diagnostic 352-bp fragment, b-tubulin primers a 550-bp fragment,
nd cdc25 primers a 463-bp fragment. The primers used were
TA2U, 59-TCAGGAAGACCAAGAGAATG-39, and RTA2L, 59-
GATAGTCAAGAGGTG TCAG-39, which are specific to the 59
nd of the murine cyclin A2 coding sequence spanning nucleotides
81 to 200 and 514 to 533 of the cDNA, respectively (Sweeney,
996); 1830, 59-CCTTCTTGTTCGGTACCTACA-39, and 1829,
9-GTATTCATGATACGGTCAGGA-39, located at the 39 end of
he coding region of the murine b-tubulin gene spanning nucleo-
ides 18 to 38 and 555 to 575, respectively; and cdc25.S, 59-CAA-
TTCAGCAACATCGTGG-39, and cdc25.AS, 59-CTGGTCTTG-
AGCCTGCTACA-39, located at the 59 end of the coding sequence
f the human cdc25 gene, spanning nucleotides 1236 to 1255 and
678 to 1698, respectively (Yokoi, 1993). Positive and negative
ontrol samples were added to the analysis, during both the RT
eaction (reaction mix with 1 mg of mouse intestine RNA for the
positive and reaction mix alone for the negative control) and the
PCR step (mouse intestine cDNA for the positive and water for the
negative controls).
Amplified DNA produced by RT-PCR was run out on 2%
agarose gels in 13 TBE and transferred to Hybond N1 membranes
(Amersham, UK) in 0.4 N NaOH overnight at room temperature.
Membranes were rinsed for 1 min in 23 SSC buffer and prehybrid-
ized in 10 mL QuikHyb solution (Stratagene) at 65°C for 30 min.
Labeling of radioactive probes was performed using [a-32P]dCTP
(110 TBq/mmol; Amersham, UK) and the kit Megaprime (Amer-
sham, UK) according to the manufacturer’s recommendations. The
DNA fragments used as probes were derived from RT-PCR-
amplified products starting with RNA extracted from mouse intes-
tine. Hybridization was carried out in QuikHyb with 1 million
counts per milliliter of labeled probe at 65°C for 2 h. The mem-
branes were washed to a stringency of 0.13 SSC, 0.1% SDS at 65°C.
Autoradiography was carried out at 280°C with intensifying
screens.
Antiserum Anti-cyclin A2
The antigen used comprised the first 148 residues of mouse
cyclin A2 expressed in a recombinant form in Escherichia coli. The
first injection was made in Freund’s complete adjuvant into the
popliteal lymph node of a rabbit. Subsequent injections were
subcutaneous using Freund’s incomplete adjuvant. The antiserum
used was that giving the highest titer on Western blotting against
murine thymus lysates and was used for the immunofluorescence
analyses. s
Copyright © 2000 by Academic Press. All rightDetection of Cyclin A2 by Immunoblotting
Groups of oocytes and embryos were collected in sample buffer
(Lae¨mmli, 1970) and heated to 100°C for 5 min. The proteins were
separated by SDS–PAGE (10% gels) and electrically transferred to
nitrocellulose membranes (Amersham Hybond-C or Schleicher and
Schuell; pore size 0.45 mm). Following transfer and blocking for 2 h
n 3% milk in TBS (10 mM Tris–HCl, pH 7.5, 140 mM NaCl),
ontaining 0.1% Tween 20 (TBS/Tween), membranes were incu-
ated overnight at 4°C with a polyclonal anti-cyclin A2 antibody
iluted 1/2000 in blocking solution. The membranes were then
ncubated in the second-layer antibody (anti-rabbit immunoglobu-
in; Amersham) conjugated to horseradish peroxidase diluted
/2000 in blocking solution for 2 h at room temperature. After
hree rinses in TBS/Tween, the cyclin A2 protein signal was
evealed using the SuperSignal substrate Western blotting system
Pierce). All experiments were repeated at least three times.
Detection of Cyclin A2 by Immunofluorescence
Samples were processed for immunofluorescence staining as
described (Sweeney, 1996; Murphy, 1997), with the following
modifications that were essential to abolish background staining.
Oocytes and embryos were collected in M21BSA and the zonae
were removed by brief treatment with acid Tyrode’s solution
(Nicholson, 1975). All samples were fixed immediately first in 4%
paraformaldehyde in PBS containing 1 mg/mL polyvinyl alcohol for
30 min and then in the same solution with the addition of 0.3%
Triton X-100 for a further 30 min. The solutions used for rinsing
and dilution of the antibodies (anti-cyclin A2 antiserum and
fluorescein-conjugated F(ab)92 fragments of anti-rabbit IgG; Boehr-
inger) contained 0.1% Tween 20. Samples were also stained with
propidium iodide (5 mg/mL for 10 min; Sigma) and mounted on
glass slides in Vectashield mounting medium (Vector Laboratories)
to prevent bleaching. All steps of the procedure were carried out at
room temperature.
The cellular localization of the cyclin A2 protein was assessed by
Confocal Laser Scanning Microscopy using a Leica confocal imag-
ing system (TCS4D; Leica Lasertechnik GmbH Germany). Images
were collected using an oil immersion lens (633, NA I.4 plan
Apochromat). For fluorescein and propidium iodide excitation, an
argon krypton laser operating at 488 nm and 568 lines, respectively,
was used. The pinhole of the confocal system was closed to allow
a minimum field depth. Optical sections were collected at 2-mm
ntervals, corresponding to the increment between two adjacent
ections in sequential mode (FITC first and propidium iodide
econd). Line averaging mode was used to integrate the signal
ollected over eight lines in order to reduce noise with a scan time
f 2 s per frame and raster size of 512 3 512 pixels. Micrographs
ere processed with Adobe PhotoShop 6.0 and images were as-
embled and printed directly from the computer on a dye sublima-
ion printer (Colorease Kodak).
BrdU Incorporation in Cultured Blastocysts and
Early Postimplantation Stage Embryos
Blastocysts cultured for 3 or 4 days in vitro were labeled with
10 mM 5-bromo-29-deoxyuridine (BrdU) for 50 min prior to fixation
n 70% ethanol in 50 mM glycine–HCl buffer (pH 2.0) for 20 min at
20°C. BrdU-positive cells were detected using a monoclonal
ntibody against BrdU and an alkaline phosphatase-conjugated
econdary antibody (BrdU Labeling and Detection Kit II; Boehringer
s of reproduction in any form reserved.
a
c
p
P
i
F
P
F
V
s
w
i
f
m
1
1
a
s
c
c
1
a
o
r
i
b
O
O
O
L
E
L
B
I
I
o
e
b
g
5
142 Winston et al.Mannheim), according to the manufacturer’s instructions, and
examined under a light microscope.
Pregnant mice (6.5 days pc) received a single intraperitoneal
injection of 400 mL BrdU (10 mg/mL in PBS) 3 h before sacrifice.
Intact deciduae were fixed overnight in 70% ethanol at 4°C and
embedded in paraffin. Sagittal sections 5 mm thick were rehydrated
nd treated with 2 N HCl for 45 min, washed twice in PBS
ontaining 0.1% Tween (PBT) for 10 min, and then incubated in
roteinase K (20 mg/mL in PBS) for 15 min. After three washes with
BT, 10 min each, embryo sections were blocked in goat serum (1%
n PBT; Sigma) for 1 h. BrdU incorporation was detected using an
ITC-conjugated anti-BrdU monoclonal antibody (dilution 1/20 in
BT 1 1% goat serum; Caltag) and incubated overnight at 4°C.
inally, after two washes in PBT, the sections were mounted in
ectashield and analyzed under a fluorescence microscope. All
teps were carried out at room temperature unless stated other-
ise.
RESULTS
The Cyclin A2 Gene Is Transcribed Actively
in GV-Stage Oocytes and Two-Cell Stage
Embryos Onward
We first wished to determine in detail the transcriptional
activity of the cyclin A2 gene during early mouse embryo
development. We used a strain of mice heterozygous for
cyclin A2 (Murphy, 1997), in which the lacZ reporter gene
is under the control of the cyclin A2 promoter in the cyclin
A2-null allele (Table 1 and Fig. 1).
b-Galactosidase activity was detected in all germinal
vesicle stage oocytes (Table 1, “GV 1 dbcAMP” and Fig.
1B), disappeared during germinal vesicle breakdown (Table
1, “GV 2 dbcAMP”), and was never observed in mature MII
oocytes recovered from mice heterozygous for cyclin A2
(1/2) nor in wild-type oocytes at any stage of oocyte
development (Table 1, Fig. 1A). We were also unable to
detect b-galactosidase activity in one-cell or recently di-
vided two-cell embryos derived from crosses, including at
least one heterozygous parent (Murphy, 1997, and Table 1).
The absence of activity also indicates that b-galactosidase is
rapidly turned over in the early mouse embryo and is
therefore a reliable reporter of the up- and downregulation
of the adjacent promoter. b-Galactosidase staining reap-
peared in late two-cell embryos, in the proportions expected
according to the parental genotypes (Table 1). Thus, cyclin
A2 promoter is silenced in mouse oocytes from the resump-
tion of meiotic maturation until activation of the zygotic
genome at the late two-cell stage.
To establish the normal pattern of cyclin A2 gene tran-
scription and distribution of the transcripts after implanta-
tion, the presence of b-galactosidase activity was assessed
n vivo in embryos between days 3.5 and 9.5 pc obtained
rom different crosses between mice wild-type (1/1) and
ice heterozygous (1/2) for cyclin A2 (Table 1 and Figs.
E–1H) and in embryos 6.5 days pc developed in vitro (Table
and Fig. 1D). The data show that the cyclin A2 gene isctively transcribed in the blastocyst, as shown by the blue
Copyright © 2000 by Academic Press. All righttaining of all the nuclei in both trophectoderm and inner
ell mass cells (Fig. 1C). Transcription continued in both
ell types in blastocyst outgrowths cultured for 3 days (Fig.
D). However, staining of in vivo embryos at 6.5 and 7.5
days pc (Figs. 1E and 1F, respectively) revealed that cyclin
A2 gene transcription is restricted to the embryonic zone
during gastrulation. Most of the embryonic cells were
stained until the somites appeared, at which time
b-galactosidase staining was particularly prominent in the
neural folds (Fig. 1G). Later in development, the percentage
of positively stained cells and the level of b-galactosidase
ctivity were considerably reduced, indicating that the
verall transcriptional activity of the cyclin A2 gene was
epressed (9.5 days pc, Fig. 1H).
In summary, the cyclin A2 gene activity is repressed after
mplantation, initially during gastrulation in the extraem-
ryonic zone, and later within the embryo.
Detection of the Maternal Cyclin A2 mRNA Stock
in Single Oocytes and Embryos
To explore how cyclin A2-null mutants complete preim-
plantation development, we examined the presence and
TABLE 1
b-Galactosidase Activity in Mouse Oocytes and Embryos
Stage / 1/1 3 ? 1/2 / 1/2 3 ? 1/2
ocytes GV 1 dbcAMP 0/198 (0%) 122/122 (100%)
ocytes GV 2 dbcAMP 0/23 (0%) 8/12 (67%)
ocytes MII 0/40 (0%) 0/14 (0%)
ate 1-cell embryos 0/39 (0%) ND
arly 2-cell embryos 0/29 (0%) ND
ate 2-cell embryos 25/45 (55%)* 16/20 (80%)*
lastocysts 42/81 (52%)* 12/18 (67%)*
mplanted embryos 6.5 dpc 13/22 (59%)* 12/18 (67%)
mplanted embryos 7.5 dpc 3/11 (27%)a 2/4 (50%)a
Implanted embryos 8.5 dpc 16/30 (53%)* 11/14 (79%)
Implanted embryos 9.5 dpc 9/14 (64%)* 12/16 (75%)
Note. Wild-type (cyclin A2 1/1) or heterozygous (cyclin A2 1/2)
females were crossed with heterozygous males. The table gives the
percentage of oocytes and embryos stained by the chromogenic
substrate X-gal at various stages of development. GV, germinal-
vesicle-stage oocytes recovered in the presence or absence of
dibutyryl cAMP (1 and 2 dbcAMP, respectively). MII, mature
ocytes arrested in metaphase of meiosis II. Preimplantation stage
mbryos, prior to (1- and early 2-cell) and after (late 2-cell and
lastocysts) the major transcriptional activation of the zygotic
enome. Postimplantation-stage embryos developed in vivo from
6.5 to 9.5 days pc. Two or more litters were analyzed in each group,
unless otherwise stated. ND, not determined.
a Only one litter analyzed.
* Not significantly different from the expected proportions of
0% (/ 1/1) and 75% (/ 1/2) X-gal-stained embryos using a x2
analysis (P , 0.05).stability of the maternal stock of cyclin A2 mRNA in
s of reproduction in any form reserved.
143Stability of Maternally Inherited Cyclin A2FIG. 1. Pattern of cyclin A2 gene transcription during early mouse development. Oocytes and embryos from mice heterozygous for cyclin
A21/2 were stained for b-galactosidase activity (blue precipitate). Postimplantation embryos were staged according to Downs and Davies
(1993) and Theiler (1989). (A) Absence of background staining in control GV oocytes from cyclin A21/1 females. (B) GV oocytes recovered
in the presence of dbcAMP to inhibit meiotic maturation. (C) Blastocysts from a heterozygote cross showing 75% of embryos heterozygous
or homozygous null mutant for cyclin A2, with all nuclei stained positively for b-galactosidase activity, and 25% of wild-type embryos not
stained. (D) Blastocyst outgrowths with stained nuclei in both the giant trophoblastic cells and the embryonic cell mass. (E) Early primitive
streak stage (6.5 days pc) embryo stained in the embryonic zone (under the arrowheads). (F) Neural plate stage embryo with no allantoic bud
(7.5 days pc) stained in the embryonic zone (under the arrowheads). Absence of staining in a wild-type littermate is shown on the left. (G)
Late headfold stage embryo (8.5 days pc) stained in the headfolds (He) but not the allantois (All). (H) 13- to 20-somite stage embryo (9.5 days
pc), showing a punctuate staining throughout the embryo. Unstained wild-type littermate is shown on the right. Original magnification
350 (A–F), 320 (G), 316 (H).
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144 Winston et al.individual oocytes and embryos derived from heterozygous
parents. RT-PCR followed by Southern blotting of the DNA
products was used to analyze single mouse oocytes and
embryos. Since the cyclin A2 gene is actively transcribed
during oocyte growth, all oocytes should inherit maternally
derived cyclin A2 mRNA. Maternal cyclin A2 mRNA was
clearly detected in all (14/14) MII oocytes and in 95%
(124/130) of early two-cell embryos examined immediately
after recovery (Table 2, line 1). Thus, the technique is
reliable and reveals that maternal cyclin A2 mRNA does
persist after fertilization.
Most maternally inherited mRNA is degraded following
activation of the zygotic genome. If this were the case for
the cyclin A2 maternal mRNA, embryos homozygous null
for the cyclin A2 gene will give a negative result following
RT-PCR analysis. The presence of cyclin A2 mRNA and
b-tubulin mRNA as an internal control was assessed simul-
taneously in 49 individual blastocysts from crosses of mice
heterozygous for cyclin A2, of which 25% are expected to
be homozygous null mutants. Indeed 24.5% of embryos
positive for b-tubulin gave no signal for cyclin A2 and
presumably therefore will represent cyclin A2-null mu-
tants. All control wild-type blastocysts (n 5 21) gave a
positive signal for both cyclin A2 and b-tubulin. These data
thus show that by the blastocyst stage, maternal cyclin A2
mRNA was no longer detectable in null-mutant embryos,
implying that it has been totally degraded by this stage.
Degradation of Maternal Cyclin A2 mRNA Occurs
Upon Activation of the Zygotic Genome and Does
Not Depend on Cell Division
The major activation of the zygotic genome at the two-
cell stage is accompanied by a progressive decline in most
but not all maternal mRNAs (Flach, 1982; Bolton, 1984). If
cyclin A2 maternal mRNA is degraded at the late two-cell
TABLE 2
Degradation of the Maternal Stock of Cyclin A2 mRNA in the Mo
Genotype of the
parents
a-Amanitin
treatment
Stage of cell
cycle/ ?
1/1;1/2 1/2 No culture Early 2-cell (G1)
1/1 1/2 2 4-cell (S/G2)
1/1 1/2 1 2-cell (G2)
1/2 1/2 2 4-cell (S/G2)
1/2 1/2 1 2-cell (G2)
Note. Cyclin A2 mRNA was detected in individual embryos by R
n the absence (2) or presence (1) of a-amanitin. The number an
right-hand column gives the percentage of embryos expected to gi
that the maternal stock of cyclin A2 mRNA is completely degradestage, embryos analyzed for the presence of cyclin A2
Copyright © 2000 by Academic Press. All rightRNA at the four-cell stage will give a positive signal only
f they inherit at least one wild-type allele. This was indeed
he case, as 89% of embryos with one wild-type parent gave
positive signal for cyclin A2 mRNA after 24 h of culture
o the four-cell stage (expected proportion 100%; Table 2,
ine 2) and this fell to 66% when both parents were
eterozygous for cyclin A2 (expected proportion 75%; Table
, line 4).
To determine the fate of cyclin A2 maternal transcripts,
roups of early two-cell embryos (G1 phase of the cell cycle)
erived from both heterozygous and wild-type crosses were
ultured for 24 h in the presence or absence of a-amanitin to
nhibit transcription of the cyclin A2 zygotic gene (Table 2).
ndividual embryos were then analyzed by RT-PCR at the
ime of the two- to four-cell transition. After 24 h of culture
n the presence of a-amanitin, embryos become blocked at
the late two-cell stage (G2 phase of the cell cycle) and show
reduced to undetectable levels of cyclin A2 mRNA (Fig.
2A). This result indicates that cyclin A2 mRNA degrada-
tion occurs at this stage and does not depend on cell
division. In the a-amanitin-treated groups, the proportion of
embryos positive for the cyclin A2 mRNA was significantly
reduced (Table 2, lines 3 and 5). The discordance between
the observed value (24 and 28% of cyclin A2-positive
embryos) and the expected proportion (0%) can be explained
by the asynchrony of development between individual
embryos recovered from different female mice after fertili-
zation in vivo. Developmentally more advanced embryos
may hence already have a small stock of zygotic transcripts
prior to their exposure to a-amanitin.
Finally, to confirm that a-amanitin treatment did not
ffect the stability of maternal cyclin A2 mRNA, we
nalyzed embryos recovered at the pronuclear stage and
ultured to the early two-cell stage with or without
a-amanitin. Individual embryos were assessed simulta-
neously for the presence of cdc25 mRNA, the levels of
Embryo at the Two-Cell Stage
Number of
embryos
analyzed
Number of
positive
embryos
% positive embryos
Observed Expected
130 124 95 100
53 47 89 100
75 18 24 0
112 74 66 75
102 29 28 0
R immediately after collection (early 2-cell) or after 24 h of culture
centage of cyclin A2 mRNA-positive embryos are indicated. The
ositive signal according to the genotype of the parents, assuming
the late 2-cell stage.use
T-PC
d per
ve a pwhich show no significant reduction in the two-cell em-
s of reproduction in any form reserved.
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145Stability of Maternally Inherited Cyclin A2bryos (Yokoi, 1993) as an internal control. While a great
variability in the signal intensity exists between individual
embryos (Fig. 2B), 95% of a-amanitin-treated embryos and
2% of control embryos gave a positive signal for cyclin A2
RNA. Of these embryos, 100% (23/23) and 91% (21/23),
espectively, were also positive for cdc25 mRNA.
Together these data demonstrate for the first time in the
ouse that maternally derived stocks of cyclin A2 mRNA
ersist in the fertilized oocyte through the first mitosis and
re then degraded at the late two-cell stage, concurrent with
he activation of the zygotic genome.
The Cyclin A2 Protein Is Not Completely
Degraded during the First Mitotic Division
We next addressed the question of cyclin A2 protein
stability at different stages of the meiotic and mitotic cell
FIG. 2. Degradation of the maternal cyclin A2 mRNA at the 2- to
2-cell (A) or 1-cell (B) stage were cultured in the presence (a-amani
were collected and analyzed for the presence of cyclin A2 (A) or cy
(2) control samples were added to the analysis during both the RT
after hybridization using probes specific for the cyclin A2 and thedivision cycles. Immunoblotting analysis revealed that cy- c
Copyright © 2000 by Academic Press. All rightlin A2 protein was already present in the oocyte. The
rotein was resolved in two forms, whose relative abun-
ances differ between the stages analyzed (Fig. 3A). The
ower form is predominant in GV oocytes and persists after
VBD, while in MII oocytes the proportion of the upper
orm is increased. After fertilization, steady-state cyclin A2
evels are significantly increased (six-fold) concurrent with
he onset of S-phase (Fig. 3A, pronuclear stage PN), indicat-
ng that cyclin A2 can be synthesized actively from mater-
al mRNA. The cyclin A2 protein becomes principally
estricted to the faster migrating lower band from this stage,
lthough the upper band did not disappear completely until
t least the two-cell stage (Fig. 3B, compare lanes 2C and
C).
The stability of the cyclin A2 protein during the first and
econd mitosis was determined by culturing embryos col-
ected at the late one-cell or two-cell stage (G2 phase of the
l transition. Fertilized embryos in G1 phase of the cell cycle at the
r absence (control) of a-amanitin. Individual oocytes and embryos
2 and cdc25 (B) mRNAs using RT-PCR. Positive (1) and negative
ion and the PCR step. The amplification products were visualized
5 cDNAs.4-cel
tin) o
clin A
reactell cycle) in the presence or absence of the protein synthe-
s of reproduction in any form reserved.
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146 Winston et al.sis inhibitor cycloheximide (CHX). Mouse embryos nearing
mitosis have already synthesized all the proteins required
to complete cell division and hence continued to progress
through mitosis, even in the presence of CHX (Howlett,
1986). They are, however, unable to synthesize proteins de
novo after dividing. In contrast, addition of CHX more than
2 h before nuclear envelope breakdown prevents mitosis. In
CHX-treated embryos blocked at the late one-cell stage,
cyclin A2 persisted but the upper band disappeared (Fig. 3B,
lane 1C). Likewise, only the lower band persisted in em-
bryos blocked upon treatment with a-amanitin for 36 h
rom the early two-cell stage (Fig. 3B, lane 2C 1
a-amanitin). Conversely, in embryos which had divided
from one- to two-cells in the presence of CHX, cyclin A2
FIG. 3. Cyclin A2 protein levels during meiotic maturation and
the first two embryonic cell cycles. Oocytes at the appropriate
stage of maturation and embryos at different developmental stages
were analyzed by immunoblotting with a polyclonal anti-cyclin A2
antibody. (A) Germinal vesicle (GV) and metaphase II (MII) oocytes.
PN, fertilized oocytes at the pronuclear stage, 300 oocytes per
sample. (B) Cycloheximide-blocked 1-cell stage embryos (1C 1
CHX) or divided CHX-treated 2-cells (2C 1 CHX) and control 2-cell
embryos divided in the absence of CHX (2C), 50 embryos per
sample. Four-cell embryos after division in the absence (4C) or
presence (4C 1 CHX) of CHX and 2-cell a-amanitin-treated em-
ryos blocked in the G2 phase of the cell cycle for 36 h (2C 1
a-amanitin), 34 embryos per sample. These experiments were
repeated three times. (C) Embryos in G2 phase (G2), arrested in
metaphase upon nocodazole treatment (M), or undergoing cytoki-
nesis (cyt.1, cyt.2) of the first (1-cell stage) or second (2-cell stage)
embryonic cell cycle, as indicated, 300 embryos per sample. (D)
Distribution of cyclin A2 in bisected mouse embryos. A, anucleate
and N, nucleate halves of 1- or 2-cell stage embryos, as indicated,
300 embryo halves (1-cell stage) and 600 embryo halves (2-cell
stage) per sample.was degraded but a small amount of the protein remained
Copyright © 2000 by Academic Press. All rightetectable on immunoblots after a longer exposure (Fig. 3B,
ane 2C 1 CHX). This suggests that degradation depends on
ell division although it is not completed at first mitosis.
After division from two to four cells, the lower form of
yclin A2 was clearly detected in four-cell embryos in S/G2
hase cultured without CHX (Fig. 3B, lane 4C). This signal
esults from neosynthesis, as four-cell embryos that had
ivided in the presence of CHX showed no detectable cyclin
2 (Fig. 3B, lane 4C 1 CHX).
To confirm the fate of cyclin A2 protein during the first
nd second mitosis, we also analyzed synchronized em-
ryos that were blocked in metaphase in the presence of
ocodazole and then released without the drug until cyto-
inesis (Fig. 3C). Cyclin A2 was present in G2 phase
mbryos at both the one-cell and the two-cell stages. Upon
reatment with nocodazole, immunoblotting demonstrated
hat cyclin A2 was redistributed between the upper and the
ower form at metaphase (Fig. 3C, M). It remained detect-
ble during the first cytokinesis (cyt.1), in contrast to the
econd cytokinesis (cyt.2), when it was degraded to unde-
ectable levels.
These results demonstrate that degradation of the mater-
al cyclin A2 is not complete during the first mitosis in
ouse embryos. However, complete degradation occurs
uring the second mitosis.
Cyclin A2 Undergoes Intracellular Relocalization
To further characterize the expression pattern of cyclin
A2, we examined its intracellular localization by immuno-
fluorescence. Cyclin A2 was detected in GV oocytes par-
ticularly at the nuclear membrane (Fig. 4A) and appeared
essentially cytoplasmic after GVBD (Fig. 4B). In MII stage
oocytes, cyclin A2 was also concentrated at two distinct
intensely stained groups of points located at an equal
distance either side of the metaphase chromatin (Fig. 4C,
indicated by an arrowhead). These labeled structures
strongly resemble the pericentriolar material situated at the
periphery of the spindle. Other cyclin A2-labeled points,
possibly microtubule-organizing centers (Maro, 1985), were
also observed in the cytoplasm (Fig. 4C, indicated by
arrows).
After fertilization, cyclin A2 accumulates in the pronu-
clei (Fig. 4D). This nuclear labeling was also observed at
later stages in S and G2 phases (Figs. 4H and 4K), but not in
G1 (Figs. 4G, 4I, and 4J). Although cyclin A2 is detected
using immunofluorescence essentially in the nucleus dur-
ing the first two cell cycles, a large pool of the cyclin A2
protein persists in the cytoplasm. This was confirmed by
Western blotting (Fig. 3D), using embryos at the late one-
cell or two-cell stage (G2 phase) that had been cut in two
halves, only one of which contained the nucleus. Cyclin A2
was detected at similar levels as a doublet in both nucleated
and enucleated halves, indicating that there is at least as
much cyclin A2 in the cytoplasm as in the nucleus. Inter-
estingly, the pool of cyclin A2 that is resistant to degrada-
tion during the first mitotic cleavage persists around the
s of reproduction in any form reserved.
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147Stability of Maternally Inherited Cyclin A2spindle and is excluded from the chromosomes at anaphase
(Fig. 4F). During the second mitotic cleavage, a transient
FIG. 4. Cyclin A2 distribution during meiotic maturation and the
were fixed, immunolabeled with a rabbit antiserum specific for cyc
the chromatin (red). Oocytes at GV stage (A), at the onset of GVBD
microtubule organizing centers (arrow) are labeled. Immunolabel
competition (E). Anaphase of the 1- to 2-cell stage transition (F). Tw
after mitosis (H). Dividing 3-cell (I) and recently divided 4-cell (J) s
blastomeres. Four-cell stage embryos in S/G2 (K) or after divisioncytoplasmic labeling was also observed at anaphase (Fig.4I), c
Copyright © 2000 by Academic Press. All rightorresponding to the protein that will be completely de-
raded before the completion of cytokinesis (Fig. 3C, lane
wo embryonic cell cycles. Maturing oocytes and fertilized embryos
2 (fluorescein, green), and stained with propidium iodide to show
and in metaphase II (C). The centrosome region (arrowheads) and
ronuclei in a fertilized oocyte (D) and no labeling with antigen
ll stage embryo in G1, 30 min after mitosis (G) and in S phase, 6 h
embryos; note the absence of nuclear labeling in recently divided
e presence of CHX (L).first t
lin A
(B),
ed p
o-ce
tageyt.2). Accordingly, no detectable staining was found in
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148 Winston et al.four-cell embryos that have divided in the presence of CHX
(Fig. 4L).
In summary, the cyclin A2 protein is located in both the
nucleus and the cytoplasm at varying levels resulting from
its relocalization at specific stages of the meiotic and the
mitotic cell cycle.
Cyclin A2-Null Embryos Develop beyond the Four-
Cell Stage in the Absence of Detectable Maternal
Cyclin A2
The data above show that little or no maternal cyclin
A2 persists after the second mitotic cell division, indi-
cating that cyclin A2-null mutant embryos reach postim-
plantation stages in the absence of cyclin A2. This
hypothesis was confirmed by immunolabeling experi-
ments in eight-cell stage embryos. To this end, we
modified our initial methods of fixation and staining by
adding a permeabilization step to avoid the trapping of
unbound antibody in the cytoplasm. This technical ap-
proach was the only one sufficiently sensitive to work on
individual cells. However, cytoplasmic staining would be
extracted under these conditions. We thus used the
presence or absence of nuclear staining as an indicator of
the state of the whole cell. We also used confocal analysis
FIG. 5. Cyclin A2 labeling in 8-cell stage embryos from heterozyg
crosses, immunolabeled with a rabbit antiserum specific for cycli
microscopy sections were projected to reconstitute the entire emb
are shown. The cyclin A2 immunolabel was restricted to interphase
shown in B and E, respectively). Dividing and recently divided cell
are not labeled (B, red nuclei).to determine precisely the location of the immunofluo- A
Copyright © 2000 by Academic Press. All rightescence signal. The reliability of the technique was
ssessed using embryos from wild-type females crossed
ith heterozygote males. All embryos (25/25 eight-cell
tage and 25/25 blastocysts) were cyclin A2 positive (not
hown), with a strictly nuclear labeling in at least one
nterphasic blastomere and no detectable labeling in
itotic cells (similar to Figs. 5B and 5C). Our initial
bservations (Murphy, 1997) suggesting the persistence
f cyclin A2 protein in cyclin A2-null mutant blastocysts
ere not reproduced under these improved experimental
onditions (Murphy, 1999). Twelve percent (5/37) of
ight-cell embryos (Figs. 5D–5F) and 16% (6/31) of moru-
ae and blastocysts (not shown) from heterozygote crosses
howed no cyclin A2-specific staining, even when the
uclear material was in interphase, and will hence rep-
esent cyclin A2-null mutants. They were, however,
orphologically normal and able to perform mitosis at
ll stages analyzed (Figs. 5A and 5D).
Together, these data show that mouse embryos lacking
etectable nuclear levels of the maternal cyclin A2 protein
re nonetheless able to divide and develop normally to the
lastocyst stage. It is thus reasonable to infer from these
ata along with those presented above that development of
ull mutants also occurs in the complete absence of cyclin
rosses. Eight-cell stage embryos were collected from heterozygote
(fluorescein), and stained with propidium iodide (red). Confocal
(A, B, D, E). Cyclin A2-negative (A, D) and positive (B, E) embryos
lei (C and F, single confocal microscopy sections from the embryos
h condensed or decondensing chromatin and no nuclear envelopeote c
n A2
ryos
nuc
s wit2.
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149Stability of Maternally Inherited Cyclin A2Cyclin A2-Null Mutant Embryos Are Able to
Implant and to Perform DNA Replication
We showed previously that cyclin A2-null mutant em-
bryos stop development immediately after implantation,
with a size and morphology similar to those of the im-
planted blastocyst (Murphy, 1997). To better understand
the events leading to this arrest, we examined in parallel
postimplantation stage embryos from heterozygote crosses
developing either in vivo or in vitro for (i) their ability to
implant and (ii) their capacity to replicate DNA by the
incorporation of BrdU.
The ability of mutant embryos to implant was monitored
in vitro using living blastocysts cultured for 3–4 days.
Blastocysts first attach to the culture dish and then hatch,
developing both an inner embryonic cell mass and migra-
tory trophoblast giant cells, easily identifiable by their large
nuclei which result from genome endoreduplication. No
difference was seen in the number of blastocysts from
heterozygous or wild-type females crossed with heterozy-
gous males, which were able to attach and form outgrowths
(mean of six experiments, more than 300 blastocysts ana-
lyzed). In addition, the presence of viable, morphologically
normal, homozygous mutant outgrowths was confirmed by
PCR genotyping (data not shown). The ability of mutant
embryos to implant was also investigated in vivo using the
lacZ gene as a genetic marker for the cyclin A2-null allele.
b-Galactosidase staining of embryos from different parental
crosses reveals an approximately appropriate proportion of
positively stained mutant embryos, although a technical
bias exists owing to the small size of cyclin A2-null mutant
embryos and resorption of deciduae (Table 1).
The question remains as to when cellular arrest occurs.
The capacity of implanted embryos to perform DNA repli-
cation was studied both in vitro and in vivo. Blastocysts
ere cultured for 4 days and BrdU was added 50 min prior
o fixing and immunolabeling. S-phase BrdU-positive nuclei
ere observed in both inner cell mass and trophoblastic
ells in 100% of blastocyst outgrowths independent of their
enotype (obtained from both heterozygous and wild-type
emales crossed with heterozygous males) (Table 3 and Fig.
A). A similar observation was made in vivo. Pregnant mice
6.5 days pc) were injected with BrdU and the embryos were
emoved 3 h later. We detected the incorporation of BrdU in
5% of nuclei in morphologically mutant embryos, al-
hough they were highly disorganized (Fig. 6B). By compari-
on, wild-type embryos contained around 60% of BrdU-
ositive nuclei (Fig. 6C). Therefore, the cyclin A2-null
utant embryos that implanted successfully were able to
eplicate their DNA without any requirement for cyclin A2.
DISCUSSION
In this report, we have investigated the fate of maternally
derived cyclin A2 in the mouse early embryo. Maternal
cyclin A2 mRNAs are laid down in the growing oocyte and
persist until the two-cell stage, at which they are degraded
Copyright © 2000 by Academic Press. All rightndependent of cell division. The maternal cyclin A2 pro-
ein is synthesized after fertilization at both the one- and
he two-cell stages and is then degraded at each mitosis.
owever, the degradation process is not fully operational
uring the first mitosis, as a fraction of cyclin A2 protein
ersists in the cytoplasm of dividing embryos. A clear and
ecisive changeover from the use of maternal to embryonic
yclin A2 mRNA occurs at the late two-cell stage, when the
yclin A2 zygotic gene is switched on in parallel with the
ajor activation of the zygotic genome and the degradation
f the maternal stock. These results imply that cyclin
2-null mutant embryos develop from the four-cell stage to
he implanted blastocyst in the absence of detectable ma-
ernal cyclin A2. The early embryonic cell division cycles
hus appear to differ from the somatic cycles in their
equirements for cyclin A2.
Stability of the Maternal Cyclin A2 mRNA
We show that the maternal cyclin A2 transcripts are
degraded concurrent with the activation of the zygotic
genome and the cyclin A2 gene itself. This is in good
agreement with previous studies showing that cyclin A2 is
expressed as both maternal and zygotic transcripts in the
two-cell stage embryo (Moore, 1996; Domashenko, 1997).
Thus, while a positive signal for maternal cyclin A2 mRNA
was obtained in virtually all early two-cell embryos, it was
no longer detectable in the majority of embryos when
transcription was inhibited in the presence of a-amanitin.
In addition, the cyclin A2 mRNA degradation pathway
functions in embryos treated with a-amanitin, even though
hey are blocked at the late two-cell stage, suggesting that
either cell division nor gene transcription is essential for
ts activation. A similar observation has been made in the
enopus embryo (Howe, 1995). This is in sharp contrast
ith the situation in adult somatic cells, in which cyclin
2 mRNAs are stable in S and G2 phases and then are
egraded at mitosis and during G1 (Maity, 1995).
a-Amanitin is known to inhibit selectively mRNA syn-
thesis (Levey and Brinster, 1978), and the synthesis of most
polypeptides is unaffected quantitatively by up to 24 h of
TABLE 3
BrdU Incorporation in Blastocyst Outgrowths
Length of the
culture period / 1/1 / 1/2
3 days n 5 210 (100%) n 5 197 (99.5%)
4 days n 5 59 (100%) n 5 30 (100%)
Note. Blastocysts from cyclin A2 1/1 wild-type or cyclin A2
1/2 heterozygous females crossed with a heterozygous male were
cultured in vitro for 3 or 4 days and then labeled with BrdU. The
number (n) of embryos analyzed and the percentage of BrdU-
positive embryos are indicated.exposure (Braude, 1979). However, we performed experi-
s of reproduction in any form reserved.
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150 Winston et al.ments to control for possible side effects of a-amanitin on
the stability of the maternal cyclin A2 mRNA. No differ-
ence was observed between control and a-amanitin-treated
FIG. 6. BrdU incorporation in embryos from heterozygote crosses
after development in vitro or in vivo. (A) Embryos were recovered
t the blastocyst stage and allowed to develop in vitro for a further
days. BrdU labeling (brown precipitate) was detected in most of
he giant cells in the trophectoderm, in cells located at the surface
f the mass of embryonic cells, and in small cells presumably
orresponding to visceral endoderm. (B and C) Sagittal sections of
n vivo implanted embryos 6.5 days pc. Both morphologically
utant (B) and normal (C) embryos were labeled for BrdU (FITC,
reen). Original magnification 3667. Note the absence of labeling
n the maternal tissue immediately surrounding the embryo,
xcept the ectoplacental cone (. in C). The trophectoderm is also
abeled (* in C). No ectoplacental cone was seen adjacent to the
utant embryo (B).one-cell and early two-cell embryos, indicating that the
Copyright © 2000 by Academic Press. All rightcyclin A2 mRNA degradation pathway does not operate
during this period. From these data, one would therefore
predict that cyclin A2 homozygous-null embryos, which
lack a functional cyclin A2 embryonic gene, will give no
signal using RT-PCR analysis from the four-cell stage, after
the maternal stocks of cyclin A2 mRNA have been de-
graded. This was indeed the case. About one-quarter of
four-cell embryos and blastocysts from heterozygote
crosses gave no signal for cyclin A2 (Table 1) and will hence
represent, at least for the most part, cyclin A2-null mu-
tants.
Stability and Localization of the Cyclin A2 Protein
Low levels of the maternal cyclin A2 protein can be
detected in immature GV mouse oocytes and throughout
meiosis. Fertilization triggers a sixfold increase in the levels
of cyclin A2 protein, which becomes cell cycle regulated.
Therefore the maternal transcripts are fully functional.
Interestingly, cyclin A2 was resolved as a doublet by West-
ern blotting. The nature of these two forms is currently
under investigation. Preliminary results indicate that the
lower form has the same apparent molecular weight as the
primary translation product, suggesting that the upper form
is the result of posttranslational modifications. The relative
abundance of the two forms switches between the oocyte
and the embryonic stages. In MII oocytes, this switch
coincides with the relocalization of some cyclin A2 protein
to cytoplasmic structures resembling the centrosomes and
the microtubule organizing centers described by Maro
(1985). It is therefore possible that cellular relocalization of
cyclin A2 may be linked to posttranslational modifications
and to its potential role in microtubule dynamics (Buendia,
1992). A transient association of cyclin A2 with the centro-
some has been described previously from preprophase to
metaphase in HeLa cells (Bailly, 1992). In addition, the
cyclin A2/Cdk2 kinase has been implicated recently in
centrosome duplication in mammalian adult cells, arguing
for a direct role of cyclin A2 in this activity (Meraldi, 1999).
In contrast to the situation in somatic cells, a proportion
of the maternal cyclin A2 protein escapes degradation
during the first mitosis in the mouse embryo. This stable
subpopulation corresponds to the primary translation prod-
uct on immunoblots (Fig. 3D) and may be equivalent to that
immunolabeled around the spindle during the first mitosis
(Fig. 4F). This result suggests that the mitotic machinery
which completely degrades cyclin A2 subsequently at the
second mitosis is not yet fully operational or recognizes
preferentially the upper modified form of cyclin A2. Of
interest is the long duration of the first mitosis that lasts in
the region of 119 min, compared to 70 min for the second
and 60 min for the third mitoses (Ciemerych, 1999). The
cyclin A2 protein might hence play a role in the prolonga-
tion of the first mitosis to allow for proper mixing of the
chromosomes originating from the male and female pronu-
clei. Following mitosis, increases in the level of cyclin A2
protein were observed as mouse embryos proceeded
s of reproduction in any form reserved.
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both on immunoblots and by immunolabeling (Figs. 4H,
4K, and 3). The protein is thus resynthesized either from
maternal stocks of cyclin A2 mRNA or de novo, requiring
the presence of zygotic mRNA.
Howe (1995) demonstrated that cyclin A protein degrada-
tion is not directly attributable to the degradation of its
mRNA in Xenopus embryos. We observed that mouse
embryos blocked in G2 of the second mitotic cell cycle (late
two-cell stage) by a-amanitin also maintain a stable stock of
cyclin A2 protein, while the maternal stock of cyclin A2
mRNA was degraded (Fig. 4).
From these observations, one would predict that from the
four-cell stage, cyclin A2 homozygous null embryos will
give no signal using immunofluorescence. In our previous
report, it was suggested that cyclin A2 protein could be
detected in cyclin A2-null mutant blastocyst stage embryos
(Murphy, 1997). However, this signal was found to be due to
a nonspecific retention of the anti-cyclin A2 antibody in the
blastocyst that was, however, abolished upon competition
with the antigen. This observation has now been corrected
(Murphy, 1999). In this report, we have greatly modified
both the method of fixation and the staining protocol and
have also used confocal analysis to determine precisely the
location of the immunofluorescence signal. Under these
improved conditions, cyclin A2 is detected as a nuclear
protein in interphase cells. However, a large pool of cyclin
A2 protein also exists in the cytoplasm, as confirmed by
Western blotting. Indeed, similar amounts of protein were
detected in both nucleated and enucleated halves of one-
and two-cell stage embryos (Fig. 3D). We observed that all
eight-cell embryos obtained from crossing wild-type and
heterozygous mice are stained positively for the presence of
the cyclin A2 protein in at least one nucleus. By compari-
son, some embryos obtained from heterozygote crosses
show no nuclear staining, even when the nuclear material
is in interphase (Fig. 5), and will hence represent cyclin
A2-null mutants. These data therefore confirm that the
maternal cyclin A2 protein is undetectable from the four-
cell stage.
DNA Synthesis in Cyclin A2-Null Mutants
The data we present here provide important information
regarding the role of cyclin A2 in early mouse embryonic
cell cycles by showing that the persistence of cyclin A2-null
mutant embryos to postimplantation stages occurs in the
absence of cyclin A2. This is in sharp contrast with the
situation in Drosophila, in which cyclin A-deficient em-
bryos stop developing when the maternal stock of protein is
exhausted (Lehner and O’Farrell, 1989). However, the ques-
tions remain as to why and how do cyclin A2-deficient
mouse embryos cease to develop after implantation, which
by definition represents the time when cyclin A2 becomes
essential. This dependence occurs at the time when cyclin
A2 transcription becomes restricted to the embryonic re-
Copyright © 2000 by Academic Press. All rightgion (Fig. 1) and cellular proliferation dramatically increases
(Snow, 1977).
We observed that the absence of the cyclin A2 gene does
not affect the ability of blastocysts to hatch from the zona
pellucida and form outgrowths in vitro. In addition, mutant
embryos which cease to develop postimplantation in vivo
maintain a recognizable structure reminiscent of a blasto-
cyst, suggesting that the absence of the cyclin A2 gene
simply leads to an abrupt arrest of cellular proliferation and
hence of development. Our analysis of cellular proliferation
showed that all cell types in day 6.5 pc wild-type or mutant
embryos were able to enter S phase, indicating that DNA
replication is not impaired in the absence of cyclin A2. In
addition, trophoblastic cells appear to perform endoreplica-
tion since large nuclei were observed similarly in wild-type
and mutant blastocyst outgrowths. This observation sug-
gests that cyclin A2 is not required for endoreplication.
Interestingly, its degradation appears to be required to allow
reinitiation of the endocycle during each endocycle (Mac-
Auley, 1998).
Cyclin A2 is known to be rate limiting for cellular
progression in S phase and mitosis in cultured mammalian
somatic cells (Resnitzky, 1995; Rosenberg, 1995), with
recent evidence indicating that it plays an essential role
until prophase in human cells (Furuno, 1999). This is
consistent with our observation that all embryonic cells,
irrespective of their genotype, can enter S phase and sug-
gests that cellular arrest is occurring later in S phase or in
G2. In addition, cyclin A2 has recently been implicated in
the coordination between S and M (Petersen, 1999; Lukas,
1999). Our results indicate that mammalian early embry-
onic cells differ from somatic cells in their requirement for
cyclin A2 to complete the cycle. However, postimplanta-
tion, while cyclin A22/2 mutants appear to be able to at
least commence S phase, they may not be able to ensure the
completion of the cell cycle and mitosis. This arrest does
not trigger the cell death program (our unpublished obser-
vations). If this explanation is correct it suggests that cyclin
A2 becomes essential for the first time as a mitotic cyclin in
the early mouse embryo, rather than at the G1/S transition
as the onset of DNA replication is clearly unaffected. A
likely explanation for their developmental arrest is there-
fore failure to ensure sufficient levels of cellular prolifera-
tion at the onset of organogenesis. This stage of develop-
ment appears as a critical “checkpoint” of cell cycle
regulators. Interestingly, embryos mutant for the compo-
nents of ubiquitin ligases (E3 enzymes), cullin-1 or -3, are
also developmentally arrested at this stage with accumula-
tion of cyclin E (Singer, 1999; Dealy, 1999; Wang, 1999), but
cullin-1-null mutants undergo a massive apoptosis.
The data presented in this report have substantiated that
the persistence of residual stocks of maternal cyclin A2
cannot explain the continued development of embryos
mutant for the gene. One hypothesis to explain this might
be that cyclin A2 is redundant with another protein during
the nongrowth period of preimplantation mouse embryo
development. While it is not known whether cyclins A1
s of reproduction in any form reserved.
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152 Winston et al.and A2 are functionally interchangeable in vivo, they share
the capacity to bind and activate the same kinases, Cdc2
and Cdk2, and are both localized to the centrosomal region
in metaphase-arrested oocytes (Sweeney, 1996, and this
report). Mice mutant for the cyclin A1 gene are viable (Liu,
1998), which means that cyclin A1 is dispensable for early
embryonic development. However, while null mutant fe-
male progeny are able to reproduce, males are sterile (Liu,
1998). Both cyclin A1 and A2 proteins are present simulta-
neously in the oocyte (Sweeney, 1996, and this report), but
their expression does not overlap during spermatogenesis
(Ravnik and Wolgemuth, 1999; our unpublished observa-
tions). Thus, functional compensation between the two
proteins might be occurring in the oocyte. Furthermore, in
addition to its functions in meiosis, cyclin A1 may play a
role in the mitotic cell cycle in certain cells (Yang, 1999).
While A-type cyclins do not show any functional overlap
with known B-type cyclins, the novel cyclin B3, which
exhibits similarities with both A- and B-type cyclins (Gal-
lant and Nigg, 1994; Jacobs, 1998), may also be a possible
candidate to compensate for the absence of cyclin A2 during
early embryonic cell cycles, although it has as yet to be
identified in mammalian cells. The study of functional
redundancy between these cyclins will form the subject of
future investigations.
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